Physician profile
Matthew Callier
NPI 1205463833
$1,924.40
in general payments reported to CMS, 2019-2025
8 companies · $459 in 2025
The $459 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $328 · 2023: $104 · 2024: $1,033 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266 · Education: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,266.41 |
| Education | $329.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $616.10 | 2022-2024 | Aequalis Ascend Flex, Variax, Triathlon |
| Medical Device Business Services, INC. | $329.99 | 2024 | |
| Alon Medical Technology | $269.12 | 2022-2025 | |
| Acera Surgical, INC. | $202.98 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $177.23 | 2024-2025 | Custom Joint, Tapestry |
| Biotissue Holdings INC. | $149.22 | 2024 | |
| Bioventus LLC | $141.46 | 2024 | Durolane |
| Depuy Synthes Sales INC. | $38.30 | 2024 | Conduit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Callier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.